Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04845906 · ClinicalTrials.gov registry record

A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

A clinical trial of Peripheral Intravenous Catheter Stabilization, sponsored by Becton, Dickinson and Company.

Completed
Registry status
120
Enrollment target
2
Study locations

NCT04845906 is a study of Peripheral Intravenous Catheter Stabilization that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 120 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04845906, a study of Peripheral Intravenous Catheter Stabilization, has completed, sponsored by Becton, Dickinson and Company.

COMPLETED
Registry status
120 participants
Enrollment target
2
Study locations

Study Summary

This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.

Interventions

  • DEVICE StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip)

Study Locations (2)

New Jersey

  • TKL Research, Inc - Fair Lawn

Pennsylvania

  • Dermico, LLC - Broomall

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-07-13
Est. Completion 2021-08-23

Sponsor

Becton, Dickinson and Company

33 total trials

What the Registry Record Tells You About NCT04845906

The ClinicalTrials.gov registry entry for NCT04845906 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Intravenous Catheter Stabilization appearing as the primary indexed condition, and to 1 intervention - of which StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip) is the first listed.

NCT04845906 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04845906 about?

NCT04845906 is a clinical study titled "A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices". This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.

What is the current status of trial NCT04845906?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2021-07-13. Estimated completion is 2021-08-23.

What conditions does trial NCT04845906 study?

This clinical trial studies the following conditions: Peripheral Intravenous Catheter Stabilization.

What interventions are being tested in trial NCT04845906?

The interventions under investigation include: StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip) (DEVICE).

Who is sponsoring clinical trial NCT04845906?

This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04845906 being conducted?

This trial has 2 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.